ATE180969T1 - Pharmazeutische zusammensetzungen enthaltend urodeoxycholicsäure - Google Patents

Pharmazeutische zusammensetzungen enthaltend urodeoxycholicsäure

Info

Publication number
ATE180969T1
ATE180969T1 AT93118886T AT93118886T ATE180969T1 AT E180969 T1 ATE180969 T1 AT E180969T1 AT 93118886 T AT93118886 T AT 93118886T AT 93118886 T AT93118886 T AT 93118886T AT E180969 T1 ATE180969 T1 AT E180969T1
Authority
AT
Austria
Prior art keywords
compositions containing
pharmaceutical compositions
acid
urodeoxycholic
urodeoxycholic acid
Prior art date
Application number
AT93118886T
Other languages
English (en)
Inventor
Aldo Olivieri
Claudio Camponeschi
Original Assignee
Bioprogress Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprogress Spa filed Critical Bioprogress Spa
Application granted granted Critical
Publication of ATE180969T1 publication Critical patent/ATE180969T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93118886T 1992-11-27 1993-11-24 Pharmazeutische zusammensetzungen enthaltend urodeoxycholicsäure ATE180969T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922721A IT1255968B (it) 1992-11-27 1992-11-27 Composizioni farmaceutiche contenenti acido ursodesossicolico

Publications (1)

Publication Number Publication Date
ATE180969T1 true ATE180969T1 (de) 1999-06-15

Family

ID=11364369

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93118886T ATE180969T1 (de) 1992-11-27 1993-11-24 Pharmazeutische zusammensetzungen enthaltend urodeoxycholicsäure

Country Status (5)

Country Link
EP (1) EP0599282B1 (de)
AT (1) ATE180969T1 (de)
DE (1) DE69325236T2 (de)
ES (1) ES2134237T3 (de)
IT (1) IT1255968B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
ITMI20012572A1 (it) * 2001-12-06 2003-06-06 Istituto Biochimico Italiano Microgranuli di acido ursodesossicolico
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
DE602005019582D1 (de) 2004-08-30 2010-04-08 Seo Hong Yoo Nervenschutzwirkung von aufgelöster udca bei einem fokalen ischämischen modell
KR20070084211A (ko) 2004-10-15 2007-08-24 유서홍 약제학적 화합물의 독성을 감소시키기 위한 방법 및 조성물
EP1819318A1 (de) * 2004-11-24 2007-08-22 Seo Hong Yoo Getrocknete formen von wässriger solubilisierter gallensäure in dosierform
BRPI0810025A2 (pt) * 2007-04-19 2014-10-14 Disphar Int Bv Formulação farmacêutica oral de liberação imediata, método para preparar uma formulação farmacêutica multiparticulada, e, uso de ácido ursodesoxicólico
MX2009001925A (es) * 2009-02-20 2010-08-20 Senosiain S A De C V Lab Composicion farmaceutica oral para uso en enfermedades respiratorias.
ITTO20111064A1 (it) * 2011-11-18 2013-05-19 Abc Farmaceutici S P A Compresse a rilascio protratto, comprendenti acido ursodesossicolico
US20220304937A1 (en) * 2015-09-16 2022-09-29 Laboratoires C.T.R.S. Pediatric formulation
CN107095858B (zh) * 2017-06-27 2020-04-10 石家庄学院 一种熊去氧胆酸胶囊及其制备方法
CN107496928B (zh) * 2017-09-11 2020-07-14 石家庄学院 一种熊去氧胆酸干混悬剂及其制备方法
CA3142991A1 (fr) * 2019-06-28 2020-12-30 Tilman Composition comprenant un extrudat thermoforme d'au moins un triterpene et/ou au moins une de leurs formes glycosylees
CN110478304B (zh) * 2019-08-20 2022-07-05 广州市金熊大健康科技有限公司 一种含有熊胆微胶囊的牙膏
AU2023313512A1 (en) * 2022-07-25 2025-01-30 Shilpa Medicare Limited Pharmaceutical compositions of nor-udca

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747539B2 (ja) * 1986-10-22 1995-05-24 東京田辺製薬株式会社 胆汁酸固形製剤
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
IT1245891B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
US5260074A (en) * 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof

Also Published As

Publication number Publication date
DE69325236D1 (de) 1999-07-15
EP0599282A1 (de) 1994-06-01
EP0599282B1 (de) 1999-06-09
ITMI922721A0 (it) 1992-11-27
ITMI922721A1 (it) 1994-05-27
ES2134237T3 (es) 1999-10-01
IT1255968B (it) 1995-11-17
DE69325236T2 (de) 2000-01-27

Similar Documents

Publication Publication Date Title
DE69325236D1 (de) Pharmazeutische Zusammensetzungen enthaltend Urodeoxycholicsäure
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
ES479474A1 (es) Procedimiento para la obtencion de una composicion a base dederivados de la piridina de accion cerebral.
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
FI890238A7 (fi) Aktiivista ainetta ohjelmoidusti vapauttavia galeenisia koostumuksia
EP0668073A3 (de) Polyester Matrix für eine pharmazeutische Zusammensetzung mit verzögerter Freigabe.
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
FI870457A0 (fi) Farmaceutiska preparatformer foer stabilisering av interferon- .
DE3862337D1 (de) Pharmazeutische zubereitungen, die ester oder amide als wirkstoffe enthalten.
NO172580C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte n-(1-alkyl-3-hydroksy-4-piperidinyl)benzamider
ATE79538T1 (de) Dispergierbare zubereitung.
ATE94765T1 (de) Pharmazeutische praeparate zur verbesserten resorption antibakterieller verbindungen.
DE68926115D1 (de) Verfahren zur behandlung von akne
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
HUT51105A (en) Pesticide comprising substituted acrylic acid ester derivatives as active ingredient and process for producing the active ingredients
BG88028A (bg) Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат
IT1204400B (it) Composizioni farmaceutiche contenente una calcitonina
ZA91115B (en) Topical compositions
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
EP0351876A3 (de) Zusammensetzung zur Steigerung der Impfungswirkung
IT1140789B (it) Esteri sostituiti dell'acido ciclopropancarbossilico e composizioni insetticide che contengono i medesimi come ingrediente attivo
DK488988D0 (da) N-(halogenbenzoyl)-n'-2-halogen-4-(1,1,2-triflour-2-(triflourmethoxy)ethoxy)-phenylurinstoffer til anvendelse i insecticider
EP0335446A3 (de) Mittel zur Behandlung von Neoplasmen
EP0355899A3 (de) Nucleotid-Derivate
HUT49621A (en) Insecticides comprising thionophosphoric acid ester as active ingredient and process for producting the active ingredients

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties